Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is interesting.
TUSTIN, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Avid Bioservices, Inc.,
a wholly-owned subsidiary of Peregrine Pharmaceuticals (Nasdaq: PPHM),
announced today it has signed a product development agreement with Medipharm
Biotech, Co., Ltd. of Shanghai, China for process and product development of
Tumor Necrosis Therapy (TNT) under current Good Manufacturing Practices
(cGMP). Avid will provide the process development and manufacturing services
to assist Medipharm in preparing for commercial launch of their radiolabeled
TNT antibody in the Peoples Republic of China (PRC).
"We are very happy to be able to assist Medipharm as they make
preparations for the commercial launch of TNT," said Jay Treat, Ph.D., Avid's
vice president of business development. "This is a comprehensive project in
which Avid will provide process development, scale-up and cGMP manufacturing
of Medipharm's TNT monoclonal antibody."
MediPharm received product approval for Iodine-131 radiolabeled Tumor
Necrosis Therapy (TNT) monoclonal antibody in the Peoples Republic of China.
The issuance of the Certificate of New Drug from the State Food and Drug
Administration (SFDA) of China for Iodine-131 radiolabeled Tumor Necrosis
Therapy (TNT) monoclonal antibody for the treatment of advanced lung cancer
represents the first radiolabeled monoclonal antibody approved for cancer
therapy in China.
About Avid Bioservices
Avid Bioservices provides a full range of cGMP manufacturing services for
the biotechnology and biopharmaceutical industries. Avid operates a state-of-
the-art cGMP biologics contract manufacturing facility and production
laboratories in Tustin, California. The company's comprehensive package of
services includes mammalian cell culture, process development, analytical
method development and regulatory support in addition to cGMP manufacturing,
purification and bulk packaging. Avid has 10 years of antibody manufacturing
experience producing monoclonal antibodies to support clinical trials ranging
from Phase I to Phase III. Avid personnel have experience manufacturing
monoclonal antibodies and recombinant proteins in batch, fed-batch and
perfusion modes. For more information about Avid, please visit
www.avidbio.com . Information on Peregrine Pharmaceuticals, Inc. may be found
at www.peregrineinc.com .
Safe Harbor Statement: This release may contain certain forward-looking
statements that are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Actual events or results may differ
from the company's expectations as a result of risk factors discussed in
Peregrine's reports on file with the U.S. Securities and Exchange Commission,
including, but not limited to, Peregrine's report on Form 10-K for the year
ended April 30, 2003 and on Form 10-Q for the quarter ended July 31, 2003.
Investor Relations Contacts:
Frank Hawkins and Julie Marshall
Hawk Associates, Inc.
(800) 987-8256 or info@hawkassociates.com
SOURCE Avid Bioservices, Inc.
lmao....how about NO BUYERS!!!
looking pathetic
came back to see if Jim has been thrown in Jail yet... looks like the Kool-Aid is still being drank here. Stock is dead...
this had a great run, and may continue to down the road (next year or so).. off to the next pick... summers a comin.
happy trading.
kids need their MacDonald's lunch money
in comparison to other promoters APS is still king IMO, from .23 60 cts
happy trading
Lets just say, its remarkable that it has not! this is a very Clean shell company, all records kept up to date etc. You don't see these types very often. That said, it can happen. I.E dilution. Extra shares for conducting further business since there is no revenue stream here(I mean that within the Viper company alone and not backed by Medipharm).
I believe the best option is to RM this, and then up-list. Of course phase 3 needs to prove viable. or another possibility is they need market money to prove up phase 3 further or simply RM to gain funds and entry into the North American markets. lots of possibilities here. They are a big pharm.
then again, they could sell to a Chinese oil entity. I hope they are smart enough not to.
keep in mind, this may stay dormant another year too.
GL
hard to speculate, but not anywhere near todays value.
yup time to move on
mine didn't either, but I found this , not sure if you posted this before,
Shanghai Medipharm Biotechnology Co., Ltd.
????:Biotech
????:021-51317084
? ?:
????:No.865 Zu Chongzhi Rd., Zhangjiang Hi-Tech Park, Pudong, Shanghai
? ?:201203
????:http://www.vivatuxin.com
????:Shanghai Medipharm Biotechnology Co., Ltd. is a foreign-invested enterprises incorporated in 2001 with registered capital of 11 million U.S. dollars. The registered address is 865 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China. Medipharm Biotech pharmaceutical company of U.S. accounted for 95% of the shares. The company is mainly engaged in monoclonal antibody drug development and industrialization, is one of the largest bio-technological and pharmaceutical companies in antibody drug development and production. The company has the ability to continue to develop innovative new drugs. The company also has a 6000 square miter GMP production plant, with an annual output of 1,000 grams of antibodies and other biological products (freeze-dried powder injection) of three million vials per year.
source
http://www.zjbpb.com/webe/companydetail.asp?id=1168
these guys are at a min of 4+ months away from seeing any results. From spud to Rig Release...then "fracking" !!
Bakken news is nothing new by any means. And! the Bakken formation is not uniform for that matter. this is where I work.
if you intend to wait 4 or 5 months, then your patience "maybe" (I use that loosely)rewarded
GL
be nice if they RM this first, then get good results..... nevertheless; waiting patiently as this could take a while.
I am hoping By May or May for that matter.
Year of the Snake = Viper = Good Luck
Happy Trading...
I'd recommend YFRM ask for their money back on this failed PR.
sure did
Good post Wiz
yup, definitely needs some sort of catalyst to move it.
may see some 52 week lows here soon
Yup, not alot but some,
seems to be a lot of accumulation the last little while. Took a very small position under 3's last week. The chart is forming nicely. As I mentioned before, anything good coming from these guys can move the price up extremely fast and into the middle upper pennies! it didn't take much weekly volume or time for the 52 week high to achieve. come on Groupon alliance!
Then again, any bad news and we're at triple zeros,
Happy Trading....
I sent an email to some of my colleagues in Colombia, and they mentioned the Gold sector down there has nothing much going on. Government is Not issuing new licenses and there is no real industry...
In APS email they mentioned "The leases were acquired 100% from a Colombian mining company".
there is a reason why the other company sold it off.
Good luck here....
Agreed; They would have to sell this whole shell then. You can't have PHD's in Pharmaceuticals drilling wells. This Management (if true) has/have solid backgrounds in their field. I'm hoping they RM this into a pharm play and not Oil and Gas as it would only make sense, but weirder things have happened.
GL
same prospector story as SWVI.
GL here
Sorry is "Not",going to happen , this index moves fast , needs to remain liquid at where it's at
Agreed, by summer
32.5 current o/s no RS is going to happen. Nice try though
agreed, that one day mailer stating really nothing about nothing and RARS is at its 52 week lows ( which went lower later I might add)
was a one day deal! RARS can do better than that. As the Sharks say..I'm out
GL Folks
"Like nearly every Chinese penny stock which has provided on-day gains of over + 500% this year" this was quote from Aim High Profits.
That said, none have nearly the potential if this RM should it even happen
the time is now Viper! tax season upon us, people have tax returns re-invest
Nice uptrend, this stock moves fast, hopefully big news to bring it back too 52 week highs
how is there 30mill volume and no buying? or bids level 2
received the VM letter and glad I didnt buy this garbage. First time I signed up with these guys and they send me this pick... time to unsubscribe!
GL to whose in...
AMBS did it, so can this! I'm still waiting on news.
I hope you're right Bob, also check out the short report. 26% or 883,713
any news or promo and its lift off.
http://otcshortreport.com/index.php?index=rars&action=view
not sure about that, its getting lower lows, but I hope you're correct
GL
be nice to see something happen this month as March is typically the best exposure.....
where's the freakin news? or is this being brought down on purpose... charts not looking good at all
I think this was a one day promo with a 390% gain Feb 19th if you were lucky! This needed more exposure.
on to the next company
Happy Trading here......
GL
tried to get some 2's today, no go! this is being played
march typically best month for penny stocks, RARS needs some big news to move it into the pennys + again
correction, does anyone know when it will start trading?